Search

everythinglearnresearchcommunity

for

Search:↓

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Cimetidine did not reduce hair growth in women with hirsutism.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

HDMHG0401-10 improves hair loss in men with androgenetic alopecia and has no major side effects.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

α-MSH and cyclic AMP boost melanin production, while cyclic GMP and melatonin reduce it.

Hirsutism is excessive male-pattern hair growth mainly caused by ovarian hormones, and severe cases may require costly treatment with side effects.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

Early diagnosis and treatment of hereditary hemochromatosis can prevent serious complications.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

The AMHR2-482A>G gene change is linked to higher PCOS risk.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

The mutant HR bmh protein mis-localizes in cells, affecting skin and hair development.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Methylmercury accumulates in mouse hair during growth, then decreases when growth stops.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Some medicines can reduce excessive hair growth in women, but more research is needed to compare treatments and consider side effects.